Candidiasis and HIV-Protease Inhibitors: The Expected and the Unexpected
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
4
Page:
49-59
Author(s):
Evelina Tacconelli, Andrea Savarino, Flavia De Bernardis, Roberto Cauda and Antonio Cassone
Cancer and Cyclooxygenase-2 (COX-2) Inhibition
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
627-634
Author(s):
J. F. Evans and S. L.. Kargman
Targeting Gene Therapy for Prostate Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
531-555
Author(s):
N. J. Maitland, L. J. Stanbridge and V. Dussupt
Viruses in Semen and Male Genital Tissues - Consequences for the Reproductive System and Therapeutic Perspectives
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
557-575
Author(s):
N. Dejucq-Rainsford and B. Jegou
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
413-424
Author(s):
Si-Shen Feng, Li Mu, Khin Yin Win and Guofeng Huang
Vaccines and Vaccine Strategies Against HIV
Journal:
Current Drug Targets
Volume:
5
Page:
71-88
Author(s):
Ivan Stratov, Robert DeRose, Damian F.J. Purcell and Stephen J. Kent
Subject Index to Volume 4
Journal:
Current Drug Targets
Volume:
5
Page:
111-117
Author(s):
Bentham Science Publishers
Endothelial Chemokines in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
145-154
Author(s):
Kent W. Christopherson II and Robert A. Hromas
Angiogenesis Inhibitors: Current & Future Directions
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1-9
Author(s):
Shaker A. Mousa and Ahmed S. Mousa
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello